⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3027407 | 1.00 | — | — | |
| SCHEMBL6068338 | 1.00 | — | — | |
| SCHEMBL179786 | 1.00 | — | — | |
| SCHEMBL11315725 | 1.00 | — | — | |
| SCHEMBL6282130 | 1.00 | — | — | |
| SCHEMBL1338748 | 0.97 | — | — | |
| SCHEMBL2385426 | 0.87 | — | — | |
| SCHEMBL2154219 | 0.83 | — | — | |
| SCHEMBL2155057 | 0.83 | — | — | |
| SCHEMBL2155118 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2488195-A2 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | F. Hoffmann-La Roche AG (CH) | 2012-08-22 | — | — | EP | claimed |
| EP-2352511-A2 | NEUROPEPTIDE-2-RECEPTOR (Y-2R) AGONISTS AND USES THEREOF | F. Hoffmann-La Roche AG (CH) | 2011-08-10 | — | — | EP | claimed |
| US-20110172147-A1 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | CONDE-KNAPE KARIN | 2011-07-14 | — | — | US | claimed |
| WO-2011045232-A2 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-04-21 | — | — | WO | claimed |
| US-20100179093-A1 | Neoropeptide-2-Receptor (Y-2R) Agonists | DANHO WALEED | 2010-07-15 | — | — | US | claimed |
| WO-2010052144-A2 | NEUROPEPTIDE-2-RECEPTOR (Y-2R) AGONISTS AND USES THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2010-05-14 | — | — | WO | claimed |
| EP-2488195-A2 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | F. Hoffmann-La Roche AG (CH) | 2012-08-22 | — | — | EP | disclosed |
| EP-2352511-A2 | NEUROPEPTIDE-2-RECEPTOR (Y-2R) AGONISTS AND USES THEREOF | F. Hoffmann-La Roche AG (CH) | 2011-08-10 | — | — | EP | disclosed |
| US-20110172147-A1 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | CONDE-KNAPE KARIN | 2011-07-14 | — | — | US | disclosed |
| WO-2011045232-A2 | NEUROPEPTIDE-2 RECEPTOR (Y-2R) AGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2011-04-21 | — | — | WO | disclosed |
| US-20100179093-A1 | Neoropeptide-2-Receptor (Y-2R) Agonists | DANHO WALEED | 2010-07-15 | — | — | US | disclosed |
| WO-2010052144-A2 | NEUROPEPTIDE-2-RECEPTOR (Y-2R) AGONISTS AND USES THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2010-05-14 | — | — | WO | disclosed |
| US-6392063-B1 | ANTICANCER DRUG | THE LIPOSOME COMPANY, INC. | 2002-05-21 | — | — | US | disclosed |